738 related articles for article (PubMed ID: 15818420)
1. [New ultrashort scheme for helicobacter pylori infection eradication using tetracyline, furazolidone and colloidal bismuth subcitrate in dyspeptic patients with or without peptic ulceration in the National Hospital Cayetano Heredia].
Araujo Castillo R; Pinto Valdivia JL; Ramírez D; Cok García J; Bussalleu Rivera A
Rev Gastroenterol Peru; 2005; 25(1):23-41. PubMed ID: 15818420
[TBL] [Abstract][Full Text] [Related]
2. [HELICOBACTER PYLORI INFECTION ERRADICATION IN DISPEPTIC PATIENTS WITH AND WITHOUT PEPTIC ULCER].
De Idiáquez D; Bussalleu A; Rodrigo I; Cabello J; Caviedes G; Cok J; León Barúa R
Rev Gastroenterol Peru; 1999; 19(3):179-194. PubMed ID: 12207204
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
4. Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
Bojarski C; Epple HJ; Kirstein FW; Fromm M; Bisson S; Riecken EO; Schulzke JD
Z Gastroenterol; 2000 Mar; 38(3):211-9. PubMed ID: 10768243
[TBL] [Abstract][Full Text] [Related]
5. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
Rodríguez Hernández H; Sánchez Anguiano LF; Quiñones E
Rev Gastroenterol Mex; 1998; 63(1):21-7. PubMed ID: 10068745
[TBL] [Abstract][Full Text] [Related]
6. Eradication of Helicobacter pylori in follicular and nonfollicular gastritis.
Mehmet S; Ozdal E; Kamil O; Beşir K; Huseyin D; Nihat A; Cigdem EY; Nusret E
Hepatogastroenterology; 2009; 56(91-92):930-4. PubMed ID: 19621732
[TBL] [Abstract][Full Text] [Related]
7. Short-term eradication therapy for Helicobacter pylori does not reduce the incidence of gastric metaplasia in duodenal ulcer patients.
Rudnicka L; Bobrzyński A; Stachura J
Pol J Pathol; 1997; 48(2):103-6. PubMed ID: 9278106
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of the effectiveness of tri- and quadricomponent eradication therapy in patients with peptic ulcer].
Butorov IV; Osoianu IuP; Butorov SI; Maksimov VV
Klin Med (Mosk); 2005; 83(12):50-3. PubMed ID: 16502725
[TBL] [Abstract][Full Text] [Related]
9. Is there any relationship between functional dyspepsia and chronic gastritis associated with Helicobacter pylori infection?
Kyzekové J; Arlt J; Arltová M
Hepatogastroenterology; 2001; 48(38):594-602. PubMed ID: 11379362
[TBL] [Abstract][Full Text] [Related]
10. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of quadruple therapy in the eradication of Helicobacter pylori and prevention of recurrent duodenal ulcer].
Ocaña Andrade E; Espinosa Soberanes JA; Mares Zambrano MA; Rosete Reyes A
Rev Gastroenterol Mex; 1998; 63(4):182-6. PubMed ID: 10319667
[TBL] [Abstract][Full Text] [Related]
12. Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection.
Dore MP; Graham DY; Mele R; Marras L; Nieddu S; Manca A; Realdi G
Am J Gastroenterol; 2002 Apr; 97(4):857-60. PubMed ID: 12003419
[TBL] [Abstract][Full Text] [Related]
13. Eradication rate of Helicobacter pylori in dyspeptic patients.
Amini M; Khedmat H; Yari F
Med Sci Monit; 2005 Apr; 11(4):CR193-5. PubMed ID: 15795700
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of the efficacy of omeprazole/bismuth subcitrate or triple therapy in Helicobacter pylori gastritis. A prospective controlled study].
Bertschinger P; Brunner J; Flury R; Lammer F; Jost R; Häcki WH
Schweiz Med Wochenschr; 1992 Sep; 122(39):1446-51. PubMed ID: 1411403
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori infection after gastrectomy and vagotomy in duodenal ulcer patients.
Sito E; Konturek PC; Konturek SJ; Bielański W; Stachura J
J Physiol Pharmacol; 1996 Mar; 47(1):229-37. PubMed ID: 8777304
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori eradication in the healing of atrophic gastritis: a one-year prospective study.
Arkkila PE; Seppälä K; Färkkilä MA; Veijola L; Sipponen P
Scand J Gastroenterol; 2006 Jul; 41(7):782-90. PubMed ID: 16785190
[TBL] [Abstract][Full Text] [Related]
17. An audit of low dose triple therapy for eradication of Helicobacter pylori.
Fraser AG; Moore L; Ali MR; Chua LE; Hollis B; Little SV
N Z Med J; 1996 Aug; 109(1027):290-2. PubMed ID: 8773671
[TBL] [Abstract][Full Text] [Related]
18. Eradication of Helicobacter pylori in duodenal ulcer disease tetracycline & furazolidone vs. metronidazole & amoxicillin in omeprazole based triple therapy.
Mansour-Ghanaei F; Fallah MS; Shafaghi A
Med Sci Monit; 2002 Mar; 8(3):PI27-30. PubMed ID: 11889461
[TBL] [Abstract][Full Text] [Related]
19. Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
Uygun A; Ozel AM; Yildiz O; Aslan M; Yesilova Z; Erdil A; Bagci S; Gunhan O
J Gastroenterol Hepatol; 2008 Jan; 23(1):42-5. PubMed ID: 17559359
[TBL] [Abstract][Full Text] [Related]
20. Non-ulcer dyspepsia and Helicobacter pylori infection--morphological analysis according to the Sydney system--changes before and after treatment.
Lewy-Trenda I; Trenda P; Wierzchniewska A
Pol J Pathol; 1996; 47(2):57-63. PubMed ID: 8854727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
